Friday 5 from Endocrinology Network - April 16

April 16, 2021
Endocrinology Network Editorial Staff

The Friday 5 from Endocrinology Network is a list composed by the Endocrinology Network editorial staff aimed at highlighting relevant coverage from endocrinology and endocrinology-related fields.

Every Friday, Endocrinology Network provides a curated list of 5 articles focused or related to a particular topic in endocrinology. This week, the Friday 5 from Endocrinology Network highlights the 5 most popular articles from the past week.

1. Race, Gender, & Income Influence Access to SGLT2 Inhibitors Among US Patients

Using data from nearly 1 million patients with type 2 diabetes in a commercial database, investigators provide a comprehensive of the impact race/ethnicity, gender, and income can have on the likelihood of receiving a prescription for SGLT2 inhibitors.

2. Obesity Tied to Heavy Menstrual Bleeding, Delayed Repair in Womb Lining

An analysis of body weight and PBAC score from 121 women in Scotland suggests the presence of obesity could be linked to heavier menstrual bleeding and cause delays in womb lining repair.

3. Disparities in Failure to Rescue Rates Drives Racial Differences in Maternal Mortality

A retrospective study from investigators at Columbia University suggests differences in rates of failure to rescue from severe maternal morbidity were a major contributor to the disparity in excess maternal mortality seen among Black women.

4. Low-Intensity Walking Program Fails to Show Benefit for Peripheral Artery Disease

A trial led by clinicians from Northwestern Medicine suggests the presence of ischemic leg symptoms could serve as a useful indicator for patients to help determine whether they will see a meaningful benefit from their walking program.

5. Stem Cells Show Promise for Non-healing Diabetic Foot Ulcers in Phase 1 Trial

New data suggest injections of adipose-derived SVF cells could elicit wound closure in patients with non-healing diabetic foot ulcers and, subsequently, reduce the need for amputation in this patient population.

Interested in more from Endocrinology Network? Subscribe to their free eNewsletters!